Back
Ryan Specialty Holdings Vs. Kymera Therapeutics Industry Stock Comparison
Buy
74
RYAN
Ryan Specialty Holdings
Last Price:
65.45
Seasonality Move:
9.37%
Buy
52
KYMR
Kymera Therapeutics
Last Price:
42.18
Seasonality Move:
-9.55%
Buy
74
Ryan Specialty Holdings (RYAN)
is a Buy
Is Ryan Specialty Holdings a Buy, Sell or Hold?
- The current Ryan Specialty Holdings [RYAN] share price is $65.09. The Score for RYAN is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- RYAN is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $41.44. The Score for KYMR is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RYAN Stock Price Chart
What is Ryan Specialty Holdings's stock price today?
-
The Ryan Specialty Holdings share price today is $65.09
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYAN is experiencing selling pressure, which indicates risk of future bearish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $41.44
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing selling pressure, which indicates risk of future bearish movement.
RYAN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.26 | Buy |
Relative Strength Index (14 RSI): | 63.79 | Buy |
Chaikin Money Flow: | -707580 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (56.94 - 63.8) | Buy |
Bollinger Bands (100): | (51.44 - 59.48) | Buy |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.09 | Buy |
Relative Strength Index (14 RSI): | 51.53 | Buy |
Chaikin Money Flow: | -161211 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.98 - 45.64) | Sell |
Bollinger Bands (100): | (32.41 - 41.21) | Buy |
RYAN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 64.76 | Buy |
20-day SMA: | 61.29 | Buy |
50-day SMA: | 58.19 | Buy |
200-day SMA: | 50.5 | Buy |
8-day EMA: | 64.34 | Buy |
20-day EMA: | 62.04 | Buy |
50-day EMA: | 58.92 | Buy |
200-day EMA: | 52.39 | Buy |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.2 | Sell |
20-day SMA: | 43.44 | Sell |
50-day SMA: | 37.14 | Buy |
200-day SMA: | 32.28 | Buy |
8-day EMA: | 41.87 | Sell |
20-day EMA: | 41.52 | Sell |
50-day EMA: | 39.06 | Buy |
200-day EMA: | 33.75 | Buy |
Ryan Specialty Holdings Earnings Growth & RYAN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.11 per share, an increase this year of $0.43 per share, and an increase next year of $0.41 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.30 per share, and a decrease next year of $0.38 per share.
Ryan Specialty Holdings Technical Analysis
Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 2 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
29 | 30 | 31 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 2 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
29 | 30 | 31 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |